Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12702257 | 0.88 | TSHR (0.46) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL31238970 | 0.87 | TSHR (0.58) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL27701389 | 0.86 | TSHR (0.56) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL4034840 | 0.85 | TSHR (0.60) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL31672310 | 0.85 | TSHR (0.60) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL68019 | 0.85 | TSHR (0.60) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL7088682 | 0.85 | TSHR (0.64) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL95376 | 0.83 | TSHR (0.62) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL13970849 | 0.81 | TSHR (0.60) | TSHRCYP3A4GPR35ALDH1A1MAPT | |
| SCHEMBL12090352 | 0.81 | TSHR (0.60) | TSHRCYP3A4GPR35ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110835361-A | Sialic acid glycosyl donor and preparation method and application thereof | 山东大学 | 2020-02-25 | — | — | CN | claimed |
| US-12275686-B2 | NO donor compound, preparation method thereof, pharmaceutical composition comprising same, and use thereof | SOUTHEAST UNIVERSITY (CN) | 2025-04-15 | — | — | US | disclosed |
| CN-116675620-B | NO donor compound, preparation method, pharmaceutical composition and application thereof | 东南大学 | 2025-01-10 | — | — | CN | disclosed |
| EP-4484409-A1 | NO DONOR COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | Southeast University (CN) | 2025-01-01 | — | — | EP | disclosed |
| US-20240409500-A1 | NO DONOR COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | SOUTHEAST UNIVERSITY (CN) | 2024-12-12 | — | — | US | disclosed |
| CN-116675620-A | NO donor compound, preparation method, pharmaceutical composition and application thereof | 东南大学 | 2023-09-01 | — | — | CN | disclosed |
| WO-2023160344-A1 | NO DONOR COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | 东南大学 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023074169-A1 | PRIMER LAYER-FORMING COMPOSITION, LAMINATE, AND METHOD FOR DECOMPOSING LAMINATE | 日産化学株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023074171-A1 | RELEASE LAYER-FORMING COMPOSITION, LAMINATE, AND METHOD FOR MANUFACTURING LAMINATE | 日産化学株式会社 | 2023-05-04 | — | — | WO | disclosed |
| US-20230077362-A1 | MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2023-03-16 | — | — | US | disclosed |
| EP-0155231-B2 | Image-producing process | CIBA GEIGY AG (CH) | 1997-01-15 | — | — | EP | disclosed |
| US-5508141-A | AQUEOUS ACIDIC PHOTORESIST EMULSION CONTAINING RESIN, POSITIVE-ACTING PHOTOACTIVE FUNCTIONALITY, ACID, OXIDIZING AGENT, SURFACTANT | W. R. GRACE & CO.-CONN. (US) | 1996-04-16 | — | — | US | disclosed |
| EP-0468002-A4 | AUTODEPOSITION EMULSION FOR SELECTIVELY PROTECTING METALLIC SURFACES | GRACE W R & CO (US) | 1995-08-09 | — | — | EP | disclosed |
| US-5232815-A | Corrosion resistance | W. R. GRACE & CO.-CONN. (US) | 1993-08-03 | — | — | US | disclosed |
| EP-0518453-A1 | A method of making electrical circuit traces | W.R. Grace & Co.-Conn. (US) | 1992-12-16 | — | — | EP | disclosed |
| EP-0468002-A1 | AUTODEPOSITION EMULSION FOR SELECTIVELY PROTECTING METALLIC SURFACES | W.R. GRACE & CO.-CONN. (US) | 1992-01-29 | — | — | EP | disclosed |
| WO-1991008840-A1 | AUTODEPOSITION EMULSION FOR SELECTIVELY PROTECTING METALLIC SURFACES | W.R. GRACE & CO.-CONN. (US) | 1991-06-27 | — | — | WO | disclosed |
| US-4808682-A | BLEND WITH OLEFINICALLY UNSATURATED SILICON COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 1989-02-28 | — | — | US | disclosed |
| US-4632900-A | Process for the production of images after electrodeposition of positive photoresist on electrically conductive surface | CIBA-GEIGY CORPORATION (US) | 1986-12-30 | — | — | US | disclosed |
| EP-0155231-A2 | Image-producing process | CIBA-GEIGY AG (CH) | 1985-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230077362-A1 | MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO | ACHE, DDT, MLYCD | TSHR 2668/4885CYP3A4 592/4885GPR35 3785/4885 |
| US-12275686-B2 | NO donor compound, preparation method thereof, pharmaceutical composition comprising same, and use thereof | HIF1A, NOS1, NOS2 | TSHR 4509/4885CYP3A4 287/4885GPR35 1048/4885 |
| US-20240409500-A1 | NO DONOR COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | HIF1A, NOS1, NOS2 | TSHR 4509/4885CYP3A4 287/4885GPR35 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.